Pulse field ablation

DEVICE3 trials

Sponsors

Biosense Webster, Inc., University Hospital, Grenoble, University Medical Centre Ljubljana

Conditions

Atrial FibrillationAtrial Fibrillation ParoxysmalLongstanding Persistent Atrial FibrillationPersistent Atrial Fibrillation

Unknown Phase

Assessment of Safety and Effectiveness in Treatment Management of Atrial Fibrillation With the BWI IRE Ablation System

CompletedNCT05293639

Biosense Webster, Inc.Atrial Fibrillation

Start: 2022-04-18End: 2023-12-11Updated: 2025-05-25

Pulsed Field Ablation vs Cryoablation In Paroxysmal Atrial Fibrillation

Active, not recruitingNCT05940597

University Hospital, GrenobleAtrial Fibrillation Paroxysmal

Start: 2023-09-01End: 2026-03-31Target: 350Updated: 2025-06-22

Electroporation for Treatment of Atrial Fibrillation

Active, not recruitingNCT06134752

University Medical Centre LjubljanaLongstanding Persistent Atrial Fibrillation, Persistent Atrial Fibrillation

Start: 2023-12-05End: 2027-05-01Target: 50Updated: 2026-02-11

Related Papers

Procedural characteristics and clinical outcomes from same-day discharge after pulsed field ablation treatment for atrial fibrillation: an admIRE trial sub-analysis.

2025-10-012 citations

Premature Ventricular Complexes After Ablation for Paroxysmal Atrial Fibrillation and Recurrent Atrial Arrhythmias: The admIRE Subanalysis.

2025-05-28

Early versus late atrial fibrillation recurrence after pulsed field ablation: insights from the admIRE trial

EP Europace2025-01-1614 citations

Pulsed Field Ablation to Treat Paroxysmal Atrial Fibrillation: Safety and Effectiveness in the AdmIRE Pivotal Trial

Circulation2024-09-1179 citations